BioCentury
ARTICLE | Financial News

Syndax amends IPO

December 8, 2014 8:00 AM UTC

Syndax Pharmaceuticals Inc., Waltham, Mass. Business: Cancer Date announced: 2014-11-21 Type: IPO To be raised: Up to $74.2 million Shares: TBD Price: TBD Underwriters: Deutsche Bank; Jefferies; JMP S...